DMRA · Damora Therapeutics, Inc.
$29.99
-3.00 (-9.09%)
At close · Jul 22
Going-concern doubt
— flagged May 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“If we are unable to raise additional capital when needed, that could raise substantial doubt about our ability to continue as a going concern.”View the 10-Q filed May 12, 2026
Market Cap
$1.85B
Shares
61.55M
Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.
Short Squeeze Score
82/100
Short interest 5.8% of shares — P77
Days to cover 2.6 — P54
Price vs VWAP +18.0% — P95
Short-volume trend +24.1% — P96
Short interest change +172.3% — P96
Worst FTD 0.93% of shares — P92
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-30). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
| 2026-06-30 | 3,567,900 | 1,310,364 | +2,257,536 | 2.63 |
| 2026-06-15 | 1,310,364 | 1,402,988 | -92,624 | 3.37 |
| 2026-05-29 | 1,402,988 | 1,290,741 | +112,247 | 4.14 |
| 2026-05-15 | 1,290,741 | 1,191,070 | +99,671 | 3.09 |
| 2026-04-30 | 1,191,070 | 1,116,620 | +74,450 | 5.51 |
| 2026-04-15 | 1,116,620 | 827,221 | +289,399 | 4.72 |
| 2026-03-31 | 827,221 | 427,713 | +399,508 | 2.46 |
| 2026-03-13 | 427,713 | 325,076 | +102,637 | 1.94 |
Showing 1–8 of 8 settlements